Mechanism of the Stille Reaction
J. Am. Chem. Soc., Vol. 122, No. 48, 2000 11781
4d (76%). IR (KBr): 1437 (vs), 1412 (vs), 1316 (vs), 1232 (vs),
mL) at -78 °C. The mixture was stirred for 16 h, allowing the bath to
reach room temperature. The resulting white suspension was quenched
with aqueous NaHCO3. The organic phase was separated, washed with
water (2 × 50 mL), and then dried over MgSO4. The solvent was
evaporated, and the residue was flash-chromatographed (silicagel/n-
hexane), giving 11 as a colorless liquid (5.56 g, 89%). d ) 1.23 g/mL.
IR (liq on NaCl): 2959 (vs), 2922 (vs), 1407 (vs), 1059 (vs), 1046 (s),
781 (s), 667 (m). 1H NMR δ (CDCl3): 1.53 (m, CH2), 1.34 (m, CH2),
1.21 (m, CH2), 0.93 (m, CH3). 13C{1H} NMR δ (CDCl3): 160.23 (ddd,
1JCF ) 238.3 Hz, 3JCF ) 22.5 Hz, 3JCF ) 5.1 Hz, o-CF), 155.4 (dt, 1JCF
1211 (vs), 1186 (vs), 1022 (vs), 781 (s), 738 (vs), 693 (vs), 634 (s),
1
466 (s). H (CDCl3): δ 7.6-7.5 (m, 2 CH), 7.5-7.4 (m, 3 CH). 19F
NMR (CDCl3/PhCl/THF): δ -78.46/-74.11/-74.78 (s, CF3), -90.97/-
86.58/-86.75 (s, o-CF), -118.64/-114.26/-115.44 (s, p-CF). Anal.
Calcd for C43H30As2Cl2F6O3PdS: C, 48.36; H, 2.83. Found: C, 48.17;
H, 2.80.
[PdR(PPh3)3](BF4) (R ) C6F5, 5a.(BF4); R ) C6Cl2F3, 5c.(BF4)).
The corresponding complex 6a,c (0.157 mmol) was added to a stirred
solution of AgBF4 (30.5 mg, 0.157 mmol) in acetone/CH2Cl2 (3/3 mL)
shielded from the light. The mixture was stirred for 30 min. The AgCl
formed was carefully filtered off, and PPh3 (41.1 mg, 0.157 mmol)
was added to the solution. The mixture was stirred for 30 min and
evaporated to dryness, affording 5a,c‚[BF4] as white solids which were
washed with diethyl ether (2 × 1 mL) and vacuum-dried.
5a‚[BF4] (91%). IR (KBr): 1481 (m), 1435 (vs), 1403 (s), 1097
(vs), 1051 (vs), 777 (m), 746 (s), 700 (vs), 523 (vs), 511 (s), 493 (m).
3
2
4
) 250.4 Hz, JCF ) 5.5 Hz, p-CF), 110.5 (dt, JCF ) 54.1 Hz, JCF
)
3.5 Hz, CSn), 106.2 (ddd, 2JCF ) 29.8 Hz, 2JCF ) 20.6 Hz, 4JCF ) 5.8
Hz, CCl), 28.7 (s, sat 3JCSn ) 20.8 Hz, CH2Me), 27.1 (s, sat 2JC
)
119
Sn
64.1 Hz, sat 2JC Sn ) 62.9 Hz, CH2), 13.5 (s, sat 4JHSn ) 2.8 Hz, CH3),
117
4
1
1
119
117
11.4 (t, JCF ) 2.0 Hz, sat JC
) 358.8 Hz, sat JC
) 343.0,
Sn
Sn
SnCH2). 19F NMR (CDCl3/THF): δ -95.05/-91.21 (d, 4JFF ) 2.4 Hz,
3
4
sat JFSn ) 5.9 Hz, o-CF), -110.99/-107.94 (t, JFF ) 2.4 Hz, sat
5JFSn ) 3.4 Hz, p-CF). 119Sn{1H} NMR (CDCl3) δ -21.47 (td, 3JFSn
)
-
1H (CDCl3): δ 7.5-7.0 (m, CH). 19F NMR (CDCl3/PhCl):
δ
5
5.9 Hz, JFSn ) 3.4 Hz). EM m/z (relative intensity): 433 (7) [M+
-113.16/-108.28 (m, o-CF), -154.29/-146.20 (s, 9BF4-), -154.34/-
C4H9], 377 (18) [M+ - 2C4H9], 321 (26) [M+ - 3C4H9], 139 (42), 41
(100). Anal. Calcd for C18H27Cl2F3Sn: C, 44.22; H, 5.55. Found: C,
44.43; H, 5.27.
146.25 (s, 10BF4-), -158.50/-154.70 (t, JFF ) 20.1 Hz, p-CF),
3
-158.96/-154.77 (m, m-CF). 31P{1H} NMR (CDCl3/PhCl): δ 23.18/
2
26.99 (d, JPP ) 26.5 Hz, 2 P), 18.67/22.53 (m, P). Anal. Calcd for
Signals Observed for Complexes Dissolved in Solvents Com-
monly Used in Stille Couplings in Different Conditions. [Pd-
C60H45BF9P3Pd: C, 62.82; H, 3.95. Found: C, 62.71; H, 4.06.
5c‚[BF4] (82%). IR (KBr): 1435 (vs), 1403 (vs), 1097 (vs), 1051
(vs), 777 (m), 746 (s), 700 (vs), 523 (vs), 511 (vs), 493 (m). 1H
(CDCl3): δ 7.4-7.2 (m, 3 CH), 7.1-7.0 (m, 2 CH). 19F NMR (CDCl3/
4
(C6Cl2F3)Cl(PPh3)2]. 19F NMR (HMPA): δ -85.78 (d, JFP ) 10.84
Hz, o-CF), -86.87 (t, 4JFP ) 6.7 Hz, o-CF), -88.05 (d, 4JFP ) 9.6 Hz,
o-CF), -117.35 (s, p-CF), -117.59 (s, p-CF), -121.01 (s, p-CF).
[Pd(C6Cl2F3)Cl(PPh3)2]:PPh3:LiCl (1:2:20). 19F NMR (HMPA):
4,trans
4,cis
THF/PhCl): δ -87.73/-82.66/-82.98 (dt,
J
) 10.5 Hz,
J
FP
FP
) 4.5 Hz, o-CF), -154.58/-148.34/-146.43 (s, 10BF4-), -154.64/-
148.39/-146.49 (s, 11BF4-), -116.75/-114.11/-112.83 (s, p-CF). 31P-
4
4
δ -86.87 (t, JFP ) 6.7 Hz, o-CF), -88.05 (d, JFP ) 9.6 Hz, o-CF),
-117.59 (s, p-CF), -121.01 (s, p-CF).
{1H} NMR (CDCl3/THF/PhCl): δ 22.93/26.6/26.83 (dtd, JPP ) 26.9
2
[Pd(C6Cl2F3)X(PPh3)2] (X
)
Cl, I):PPh3 (1:2). 19F NMR
Hz, 4,cisJFP ) 4.5 Hz, 6,cisJFP ) 29 Hz, 2 P), 18.31/22.55/22.03 (tt, 2JPP
) 26.9 Hz, 4,transJFP ) 10.5 Hz, P). Anal. Calcd for C60H45P3BCl2F7Pd:
C, 61.07; H, 3.84. Found: C, 61.18; H, 4.22.
4
(HMPA): δ -86.87 (t, JFP ) 6.5 Hz, o-CF), -117.59 (s, p-CF).
[Pd(C6Cl2F3)(OTf)(PPh3)2]:PPh3 (1:2). 19F NMR (HMPA):
δ
-74.12 (s, CF3), -86.86 (t, 4JFP ) 6.5 Hz, o-CF), -117.58 (s, p-CF).
trans-[Pd(C6F5)ClL2] (L ) PPh3, 6a; AsPh3, 6b). L (3.88 mmol)
was added to a stirred suspension of [Pd2(C6F5)2(µ-Cl)2(tht)2] (700 mg,
0.882 mmol), yielding a white precipitate. The mixture was stirred for
1 h and evaporated to dryness. The solid was washed with diethyl ether
and recrystallized at -28 °C from CH2Cl2.
[Pd(C6Cl2F3)(PPh3)3](BF4):PPh3 (1:1). 19F NMR (HMPA):
δ
4
-86.85 (t, JFP ) 6.5 Hz, o-CF), -117.58 (s, p-CF), -147.59 (s,
10BF4-), -147.64 (s, 11BF4-).
[Pd(C6Cl2F3)I(PPh3)2]. 19F NMR (NMP): δ -88.07 (t, JFP ) 6.5
4
6a (98%). IR (KBr): 1502 (s), 1458 (vs), 1433 (vs), 1098 (s), 952
(vs), 744 (s), 693 (vs), 523 (vs), 513 (s), 498 (m). 1H (CDCl3): δ 7.7-
7.6 (m, 2 CH), 7.45-7.3 (m, 3 CH). 19F NMR (CDCl3/PhCl/THF): δ
-117.40/-112.59/-113.34 (m, o-CF), -162.82/-158.53/-160.12 (t,
3JFF ) 20.1 Hz, p-CF), -163.16/-158.61/-160.43 (m, m-CF). 31P-
Hz, o-CF), -117.65 (s, p-CF). After addition of 1 equiv of AgBF4:
4
-86.35 (t, JFP ) 7.1 Hz, o-CF), -115.62 (s, p-CF).
[Pd(C6Cl2F3)(OTf)(PPh3)2]. 19F NMR (NMP): δ -74.56 (s, CF3),
4
-86.37 (t, JFP ) 7.6 Hz, o-CF), -115.64 (s, p-CF).
Catalytic and Stoichiometric Experiments. These were carried out
4
{1H} NMR (CDCl3/PhCl/THF): δ 24.93/29.36/29.31 (td, JFP ) 7.3
in NMR tubes (5 mm) similarly as reported before.1
6
Hz, JFP ) 2.4 Hz). Anal. Calcd for C42H30ClF5P2Pd: C, 60.52; H,
Determination of Equilibria in Equations 2 and 3. NMR tubes
(5 mm) were charged with 4c (5.9 ( 0.1 mg) and an excess of PPh3.
The samples were dissolved under N2 in THF, PhCl, or CH2Cl2 and
taken to a volume of 600 ( 5 µL, giving a concentration of (10.0 (
0.2) × 10-2 mol L-1 in Pd. An acetone-d6 capillary was introduced
(for NMR lock), and the tubes were placed into a thermostated probe
at 323.2 ( 0.2 K (the temperature was checked by an ethylene glycol
standard method). After several minutes, 19F and 31P{1H} spectra were
carefully acquired using relaxation times long enough for meaningful
integration of signals of the complexes 4c, 5c+, or 7c+, and free PPh3.
Numerical analysis leads to the K values reported for eqs 2 and 3.
NMR Characterization of trans-[Pd(C6Cl2F3)(CHdCH2)(PPh3)2]
(10). A crude sample of 10 was obtained as follows. Complex 4c (300
mg, 0.306 mmol) was dissolved in CH2Cl2 (30 mL) and heated at 50
°C in a septum-capped tube. Organotin 2 (1.80 mL, 6.12 mmol) was
then added via syringe, whereupon the solution suddenly turned deep
brown. After 30 min, the mixture was cooled in an ice bath and
evaporated to dryness. The residue was washed with cold n-hexane (2
× 10 mL) to remove the excess of 2 and then extracted in diethyl
ether (3 × 10 mL). Evaporation of the ethereal solution at 0 °C afforded
a greenish powder which contained about 70% of 10. This degree of
purity sufficed for unambiguous NMR characterization. 1H NMR
(CDCl3): δ 7.5-7.3 (m, arom-CH), 6.32 (ddt, transJHH ) 18.3 Hz, cisJHH
3.63. Found: C, 60.76; H, 3.77.
6b (95%). IR (KBr): 1057 (vs), 1045 (vs), 780 (vs), 702 (vs). H
1
(CDCl3): δ 7.62 (m, 2 CH), 7.45-7.30 (m, 3 CH). 19F NMR (CDCl3/
PhCl/THF): δ -116.46/-111.82/-112.51 (m, o-CF), -161.77/-
157.59/-159.33 (t, 3JFF ) 20.3 Hz, p-CF), -163.00/-158.44/-160.02
(m, m-CF). Anal. Calcd for C42H30As2ClF5Pd: C, 54.75; H, 3.28.
Found: C, 54.53; H, 3.44.
trans-[Pd(C6Cl2F3)(THF)(PPh3)2](BF4) (7c‚(BF4)). Complex 6c
(0.136 g, 0.157 mmol) was added to a stirred solution of AgBF4 (30.5
mg, 0.157 mmol) in THF (6 mL) shielded from the light. The mixture
was stirred for 30 min. The AgCl formed was carefully filtered off,
and the solution was evaporated to dryness. The white residue was
dissolved in CH2CH2 (2 mL) and THF (one drop), layered with
n-hexane (3 mL), and kept at -28 °C. Separated microcrystalline 7c‚
[BF4] was collected and dried with N2 (55%). IR (KBr): 1634 (m),
1482 (m), 1435 (vs), 1410 (vs), 1098 (vs), 1084 (s), 1053 (s), 998 (m),
1
779 (m), 744 (m), 707 (m), 693 (vs), 523 (vs), 511 (s), 495 (m). H
NMR (CDCl3): δ 7.6-7.4 (m, 30 H, CH), 3.72 (m, 4 H, OCH2), 1.84
(m, 4 H, CCH2). 19F NMR (CDCl3/PhCl/THF): δ -91.87/-87.36/-
4
6
87.40 (t, JFP ) 7.6 Hz, o-CF), -118.58/-114.52/-116.18 (t, JFP
)
2.9 Hz, p-CF), -154.71/-145.04/-154.21 (s, BF4-). 31P{1H} NMR
(CDCl3/PhCl/THF): δ 23.44/27.46/27.50 (td, JFP ) 7.5 Hz, JFP
4
6
)
3
cis
3.0 Hz). Anal. Calcd for C46H38BCl2F7OP2Pd: C, 55.82; H, 3.87.
Found: C, 55.77; H, 3.68.
Sn(C6Cl2F3)Bu3 (11). SnClBu3 (3.48 mL, 12.8 mmol) was slowly
added to a solution of [Li(C6Cl2F3)] (14.02 mmol) in diethyl ether (60
) 11.3 Hz, JHP ) 9.0 Hz, CHPd), 5.16 (broad d,
J
) 11.3 Hz,
HH
4
4JHP < 3 Hz, CCH), 4.14 (broad d,
J
) 18.3 Hz, JHP < 3 Hz,
trans
HH
CCH). 19F NMR (CDCl3/PhCl/THF/CH2Cl2): δ -90.85/-85.79/-
86.10/-86.67 (t, 4JFP ) 3.1 Hz, o-CF), -123.13/-118.22/-119.46/-